Pursuant to Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the Annual Report of KMS Medisurgi Limited for the Financial Year 2025-26.

KMS MEDISURGI LIMITED | ANNUAL REPORT 2026 BOARD OF DIRECTORS CORPORATE I NFORMATION Mr. Siddharth Gaurang Kanakia Chairman & M anaging Director Mr. Rohan Devang Kanakia Non-Executive Non Independent Director Ms. Monali Gaurang Kanakia Executive Director Mr. Gaurang Prataprai Kanakia Non-Executive Non Independent Director Mr. Hardik Rajnikant Bhatt Independent D irector Mr. Kamlesh Rajani Chunilal Independent Director Mr. Pratik Pravin Tarpara Independent Director (ceased to be an Independent Director of the Company with effect fro m 30th September, 2025,) KEY MANAGERIAL PERSONNEL Mr. Anand Prataprai Kanakia Chief Fin ancial Officer Mrs. Pooja Soni Company Secretary and Compliance Officer (w.e.f. 27th June, 2025) SECURITIES LISTED ON CORPORATE IDENTITY NUMBER BSE Limited (SME Platform) L51397MH1999PLC119118 SECRETARIAL AUDITORS STATUTORY AUDITORS Naveen Karn & Co. M/s H.H. Dedhia & Associates 104, Deewan Shopping Center, 22/24 Kazi Syed Street, Masjid Bunder (W), Dindayal Nagar, Manickpur, Mumbai – 400009 Vasai (w), Palghar-401202 REG ISTERED OFFICE 297/301, Groun d Floor, May Building, Princess Street, Marine L ines (East), Mumbai 400 002. Contact No.: 022-66107722 Email ID: info@kmsgroup.in Website: www.kmsgroup.in REGISTRAR & SHARES TRANSFER AGENT KFIN Technologies Limited Karvy Selenium Tower B, Plot 31-32, Gachibowli, Financial District, Nanakramguda, Hyde rabad, Karnataka 500032 Cont act No.: +91 40 67161524 Email ID : einward.ris@kfintech.com We bsite: www.kfintech.com CONTENTS OF THE REPORT Sr.no Particulars Page Number 1 Notice of Annual General Meeting 1  Notes to Notice 1-7  Annexure to Notice 8-11 2 Directors Report 12 – 26  Annexure A ( AOC-2 Disclosure regarding Contracts & Arrangements 27 – 29 with Related Parties) 30 – 33  Annexure B ( MR-3, Secretarial audit Report) 34 – 39  Annexure C (Management Discussion & Analysis) 40 – 42  Annexure D (Appointment & remuneration of Managerial Personnel)  Annexure E (Conservation of Energy, Technology absorption & 43 – 44 Foreign Exchange outgo) 3 Certification of Non Disqualification of Directors 45 4 Declaration by Managing Director 46 5 MD/CFO Certification 47 7 Independent Auditor’s Report 48 - 66 8 Financial Statement 67-88 KMS MEDISURGI LIMITED | ANNUAL REPORT 2026 NOTICE OF ANNUAL GENERAL MEETING NOTICE is hereby given that the 28th Annual General Meeting of the Members of KMS Medisurgi Limited will be held on Wednesday, September 30, 2026 at 3.00 p.m. at its Registered Office situated at 297/301 May Building, Gr. Floor Marine lines(East), Princess Street, Mumbai-400002 to transact the following business. ORDINARY BUSINESS: 1. Adoption of Financial Statement: To receive, consider and adopt the Standalone Financial Statements of the Company for the financial year ended March 31, 2026 the Statement of Profit & Loss and Cash Flow Statement, for the year ended on that date and reports of the Board of Directors (“Board”) and Auditors thereon. 2. Declaration of Dividend: To declare a final dividend of ₹ 0.05 (0.5%) per equity share for the Financial Year ended March 31, 2026. 3. Re- appointment of Mr. Rohan Devang Kanakia (DIN: 09220915) as a Director liable to retire by rotation: To appoint a Director in place of Mr. Rohan Devang Kanakia (DIN: 09220915), who retires by rotation and being eligible offers himself for reappointment. NOTES: 1. A MEMBER ENTITLED TO ATTEND AND VOTE AT THE MEETING IS ENTITLED TO APPOINT A PROXY TO ATTEND AND VOTE ON POLL INSTEAD OF HIMSELF AND THE PROXY NEED NOT BE A MEMBER OF THE COMPANY. Pursuant to the provisions of section 105 of the Companies Act, 2013, a person can act proxy on behalf of members not exceeding fifty (50) and holding in aggregate not more than ten percent of the total share capital of the Company. Member holding more than ten percent of the total Share Capital of the Company may appoint a single person as proxy, who shall not act as a proxy for any other Member. The instrument of Proxy in order to be effective should be returned to the Registered Office of the Company, duly completed signed and stamped not less than FORTY–EIGHT HOURS before the commencement of the. Proxies submitted on behalf of limited companies, societies, etc. must be supported by appropriate resolution/authority, as applicable, issued by the member organization. A Proxy form is sent herewith. 2. The AGM Notice is being sent to the shareholders of the Company whose names appear on the Register of Members/List of Beneficial Owners as received from the Depositories as on Friday, September 4, 2026. KMS MEDISURGI LIMITED | ANNUAL REPORT 2026 3. The Register of Members and Share Transfer Books will be closed from Thursday, 24thSeptember, 2026 to Wednesday, 30th September, 2026 (both days inclusive). 4. The voting right of all shareholders shall be in proportion to their share in the paid up equity share capital of the company as on the cut-off date i.e. Wednesday, September 23, 2026. 5. Members are requested to send all communications relating to shares to our Registrar & Share Transfer Agent (R & T Agent) at the following address: KFin Technologies Ltd., Karvy Selenium Tower B, Plot 31-32, Gachibowli, Financial District, Nanakramguda ,Hyderabad, Karnataka - 500032, Phone No. 040 - 67162222; Fax No. 040-23431551,Email: web www.karisma.karvy.com, kmsmedisurgi.ipo@karvy.com 6. Members/ Proxies are requested to bring the attendance slips duly filled in and copies of the Annual Report to the Meeting. The identity/signature of the members holding shares in electronic/demat form is liable for verification with specimen signatures as may be furnished by NSDL/CDSL to the Company. Such members are advised to bring relevant identity card, issued by the Depository Participant to attend the Annual General Meeting. 7. Corporate members intending to send their authorized representatives to attend the meeting are requested to send to the Company a certified true copy of the Board Resolution authorizing their representative along with their specimen signature to attend and vote on their behalf at the meeting. 8. In case of joint holder, only joint holder who is higher in the order of names will be entitled to vote. 9. All the material documents referred to in the Resolutions are open for inspection at the Company’s Registered Office 297/301 May Building, Gr. Floor Marine lines (East) Princess Street Mumbai-400002 on all working days, except Sundays, between 10.00 A.M. to 1.00 P.M. till September 30, 2026 and will also be available for inspection at the Meeting. 10. Shareholders can register their complaints, if any on cskms99@gmail.com. 11. To prevent fraudulent transactions, members are advised to exercise due diligence and notify the Company of any change in address or demise of any member as soon as possible. Members are also advised not to leave their demat account(s) dormant for long. Periodic statement of holdings should be obtained from the concerned Depository Participant and holdings should be verified. 12. The Securities and Exchange Board of India (SEBI) has mandated the submission of Permanent Account Number (PAN) by every participant in securities market. Members holding shares in electronic form are therefore, requested to submit the PAN to their Depository Participant(s) with whom they are maintaining their demat accounts. Members holding shares in physical form can submit the PAN details to the Registrar and Share Transfer Agents/Company. KMS MEDISURGI LIMITED | ANNUAL REPORT 2026 13. In compliance with Sections 108 and 110 of the Act and the rules made thereunder and the MCA Circulars, the Company has provided the facility to the shareholders to exercise their votes electronically and vote on the resolutions through the e-voting service facility arranged by KfinTech. The instructions for e-voting are provided as part of this AGM Notice. 14. The voting rights for Equity Shares are one vote per Equity Share, registered in the name of the members. Voting rights shall be r [Showing first 8,000 characters — download PDF for full document]